Lack of the transcriptional coactivator OBF-1 prevents the development of systemic lupus erythematosus-like phenotypes in Aiolos mutant mice

Journal of Immunology

Volumn 170, Issue 4, 2003, Pages 1699-1706

  Sun, Jian ^a   Matthias, Gabriele ^a   Mihatsch, Michael J ^b   Georgopoulos, Katia ^c   Matthias, Patrick ^a  

^a FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH   (Switzerland)

^b UNIVERSITY OF BASEL   (Switzerland)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; DNA ANTIBODY; IMMUNOGLOBULIN; TRANSCRIPTION COACTIVATOR OBF 1; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AIOLOS; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE MUTATION; GENOTYPE; GERMINAL CENTER; GLOMERULONEPHRITIS; HISTOPATHOLOGY; IMMUNE COMPLEX NEPHRITIS; IMMUNOGLOBULIN PRODUCTION; IMMUNOHISTOCHEMISTRY; KNOCKOUT MOUSE; MOUSE; NONHUMAN; NULL ALLELE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0037442214     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.170.4.1699     Document Type: Article

References (41)

1. Strubin, M., J. W. Newell, and P. Matthias. 1995. OBF-1, a novel B cell-specific coactivator that stimulates immunoglobulin promoter activity through association with octamer-binding proteins. Cell 80:497.
2. Luo, Y., and R. G. Roeder. 1995. Cloning, functional characterization, and mechanism of action of the B-cell-specific transcriptional coactivator OCA-B. Mol. Cell. Biol. 15:4115.
3. Gstaiger, M., L. Knoepfel, O. Georgiev, W. Schaffner, and C. M. Hovens. 1995. A B-cell coactivator of octamer-binding transcription factors. Nature 373:360.
4. Schubart, D. B., A. Rolink, M. H. Kosco-Vilbois, F. Botteri, and P. Matthias. 1996. B-cell-specific coactivator OBF-1/OCA-B/Bob1 required for immune response and germinal centre formation. Nature 383:538.
5. Kim, U., X. F. Qin, S. Gong, S. Stevens, Y. Luo, M. Nussenzweig, and R. G. Roeder. 1996. The B-cell-specific transcription coactivator OCA-B/OBF-1/Bob-1 is essential for normal production of immunoglobulin isotypes. Nature 383:542.
6. Nielsen, P. J., O. Georgiev, B. Lorenz, and W. Schaffner. 1996. B lymphocytes are impaired in mice lacking the transcriptional co-activator Bob1/OCA-B/OBF1, Eur. J. Immunol. 26:3214.
7. Greiner, A., K. B. Muller, J. Hess, K. Pfeffer, H. K. Muller-Hermelink, and T. Wirth. 2000. Up-regulation of BOB.1/OBF.1 expression in normal germinal center B cells and germinal center-derived lymphomas. Am. J. Pathol. 156:501.
8. Hansen, J. D., P. Strassburger, and L. Du Pasquier. 1997. Conservation of a master hematopoietic switch gene during vertebrate evolution: isolation and characterization of Ikaros from teleost and amphibian species. Eur. J. Immunol. 27:3049.
9. Ford, E., M. Strubin, and N. Hernandez. 1998. The Oct-1 POU domain activates snRNA gene transcription by contacting a region in the SNAPc largest subunit that bears sequence similarities to the Oct-1 coactivator OBF-1. Genes Dev. 12:3528.
10. Qin, X. F., A. Reichlin, Y. Luo, R. G. Roeder, and M. C. Nussenzweig. 1998. OCA-B integrates B cell antigen receptor-, CD40L- and IL 4-mediated signals for the germinal center pathway of B cell development. EMBO J. 17:5066.
11. Morgan, B., L. Sun, N. Avitahl, K. Andrikopoulos, T. Ikeda, E. Gonzales, P. Wu, S. Neben, and K. Georgopoulos. 1997. Aiolos, a lymphoid restricted transcription factor that interacts with Ikaros to regulate lymphocyte differentiation. EMBO J. 16:2004.
12. Koipally, J., A. Renold, J. Kim, and K. Georgopoulos. 1999. Repression by Ikaros and Aiolos is mediated through histone deacetylase complexes. EMBO J. 18:3090.
13. Georgopoulos, K. 1997. Transcription factors required for lymphoid lineage commitment. Curr. Opin. Immunol. 9:222.
14. Wang, J. H., N. Avitahl, A. Cariappa, C. Friedrich, T. Ikeda, A. Renold, K. Andrikopoulos, L. Liang, S. Pillai, B. A. Morgan, et al. 1998. Aiolos regulates B cell activation and maturation to effector state. Immunity 9:543.
15. Vyse, T. J., and B. L. Kotzin. 1998. Genetic susceptibility to systemic lupus erythematosus. Annu. Rev. Immunol. 16:261.
16. Risch, N. 2000. Searching for genes in complex diseases: lessons from systemic lupus erythematosus. J. Clin. Invest. 105:1503.
17. Li, Y. S., K. Hayakawa, and R. R. Hardy. 1993. The regulated expression of B lineage associated genes during B cell differentiation in bone marrow and fetal liver. J. Exp. Med. 178:951.
18. Lahita, R. G. 1999. The role of sex hormones in systemic lupus erythematosus. Curr. Opin. Rheumatol. 11:352.
19. Gong, S., and M. C. Nussenzweig. 1996. Regulation of an early developmental checkpoint in the B cell pathway by Ig β. Science 272:411.
20. Melchers, F., E. ten Boekel. T. Seidl, X. C. Kong, T. Yamagami, K. Onishi, T. Shimizu, A. G. Rolink, and J. Andersson. 2000. Repertoire selection by pre-B-cell receptors and B-cell receptors, and genetic control of B-cell development from immature to mature B cells. Immunol. Rev. 175:33.
21. Stief, A., G. Texido, G. Sansig, H. Eibel, G. Le Gros, and H. van der Putten. 1994. Mice deficient in CD23 reveal its modulatory role in IgE production but no role in T and B cell development. J. Immunol. 152:3378.
22. Riffo-Vasquez, Y., D. Spina, M. Thomas, T. Gilbey, D. M. Kemeny, and C. P. Page. 2000. The role of CD23 on allergen-induced IgE levels, pulmonary eosinophilia and bronchial hyperresponsiveness in mice. Clin. Exp. Allergy 30:728.
23. Schubart, K., S. Massa, D. Schubart, L. M. Corcoran, A. G. Rolink, and P. Matthias. 2001. B cell development and immunoglobulin gene transcription in the absence of Oct-2 and OBF-1. Nat. Immunol. 2:69.
24. Kelsoe, G. 1996. The germinal center: a crucible for lymphocyte selection. Semin. Immunol. 8:179.
25. Tarlinton, D. 1998. Germinal centers: form and function. Curr. Opin. Immunol. 10:245.
26. Desai-Mehta, A., L. Lu, R. Ramsey-Goldman, and S. K. Datta. 1996. Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production. J. Clin. Invest. 97:2063.
27. Koshy, M., D. Berger, and M. K. Crow. 1996. Increased expression of CD40 ligand on systemic lupus erythematosus lymphocytes. J. Clin. Invest. 98:826.
28. Volkers, N. 1999. Do autoimmune diseases raise the risk of cancer? J. Natl. Cancer Inst. 91:1992.
29. +/- mice. Science 285:2122.
30. Wakeland, E. K., A. E. Wandstrat, K. Liu, and L. Morel. 1999. Genetic dissection of systemic lupus erythematosus. Curr. Opin. Immunol. 11:701.
31. Tsao, B. P., R. M. Cantor, J. M. Grossman, N. Shen, N. T. Teophilov, D. J. Wallace, F. C. Arnett, K. Hartung, R. Goldstein, K. C. Kalunian, et al. 1999. PARP alleles within the linked chromosomal region are associated with systemic lupus erythematosus. J. Clin. Invest. 103:1135.
32. Cohen, P. L., and R. A. Eisenberg. 1991. Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. Annu. Rev. Immunol. 9:243.
33. Theofilopoulos, A. N., R. Kofler, P. A. Singer, and F. J. Dixon. 1989. Molecular genetics of murine lupus models. Adv. Immunol. 46:61.
34. Gross, J. A., J. Johnston, S. Mudri, R. Enselman, S. R. Dillon, K. Madden, W. Xu, J. Parrish-Novak, D. Foster, C. Lofton-Day, et al. 2000. TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease. Nature 404:995.
35. Majeti, R., Z. Xu, T. G. Parslow, J. L. Olson, D. I. Daikh, N. Killeen, and A. Weiss. 2000. An inactivating point mutation in the inhibitory wedge of CD45 causes lymphoproliferation and autoimmunity. Cell 103:1059.
36. Wu, J., J. Wilson, J. He, L. Xiang, P. H. Schur, and J. D. Mountz. 1996. Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease. J. Clin. Invest. 98:1107.
37. Yasutomo, K., T. Horiuchi, S. Kagami, H. Tsukamoto, C. Hashimura, M. Urushihara, and Y. Kuroda. 2001. Mutation of DNASE1 in people with systemic lupus erythematosus. Nat. Genet. 28:313.
38. Kitamura, D., A. Kudo. S. Schaal, W. Muller, F. Melchers, and K. Rajewsky. 1992. A critical role of λ5 protein in B cell development. Cell 69:823.
39. Busslinger, M., S. L. Nutt, and A. G. Rolink. 2000. Lineage commitment in lymphopoiesis. Curr. Opin. Immunol. 12:151.
40. Chen, C., Z. Nagy, M. Z. Radic, R. R. Hardy, D. Huszar, S. A. Camper, and M. Weigert. 1995. The site and stage of anti-DNA B-cell deletion. Nature 373:252.
41. Melamed, D., R. J. Benschop, J. C. Cambier, and D. Nemazee. 1998. Developmental regulation of B lymphocyte immune tolerance compartmentalizes clonal selection from receptor selection. Cell 92:173.